Travere Therapeutics Inc (TVTX) Stock: The Story of a 52-Week Stock Range

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Travere Therapeutics Inc’s current trading price is -33.14% away from its 52-week high, while its distance from the 52-week low is 109.02%. The stock’s price range for this period has been between $8.09 and $25.29 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 3.76 million for the day, a number notably higher than the average daily volume of 1.54 million over the last three months.

At present, Travere Therapeutics Inc (TVTX) has a stock price of $16.91. In the previous session, the stock saw a rise, peaking at $47.0 after an opening price of $16.91. The day’s lowest price was $23.0, and it closed at $17.24.

Travere Therapeutics Inc ‘s stock market performance has been somewhat erratic.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Travere Therapeutics Inc (TVTX) has experienced a quarterly decline of -16.41% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.50B and boasts a workforce of 385 employees.

Travere Therapeutics Inc: What Analysts Are Saying

As of right now, 11 analysts are rating Travere Therapeutics Inc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 16.81, with a change in price of -2.82. Similarly, Travere Therapeutics Inc recorded 1,654,623 in trading volume during the last 100 days, posting a change of -14.29%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for TVTX stands at 12.20. Similarly, the long-term debt-to-equity ratio is also 9.93.

TVTX Stock Stochastic Average

Travere Therapeutics Inc’s raw stochastic average for the past 50 days is presently 84.76%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 77.53%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 82.03% and 69.40%, respectively.

TVTX Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a gain of 98.24%.However, over the last six months, we can see a stronger performance of -20.27%. Over the last 30 days, the price of TVTX has fallen by 3.55%. And in the last five days, it has surged by 9.45%.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.